Collegium Pharma to Relocate Headquarters to Downtown Boston in 2027

RTTNews··Read original
1▲0 ▼0Impact / 5
Summary · why it matters

Collegium Pharmaceutical plans to relocate its corporate headquarters to One Lincoln in Downtown Boston in the first quarter of 2027. The new headquarters will be at a property owned and managed by DivcoWest. President and CEO Vikram Karnani said the move reflects the company's confidence in its direction. Avison Young served as Collegium's real estate advisor for the site selection and lease negotiation.

Impact on assets 1

Aging Population▲ · 1 stocks
Collegium Pharmaceutical Inc
COLL
± MixedCapitalrelevance

Relocating headquarters to a new office is a capital/operational move; no clear positive or negative financial impact stated.

Off-coverage companies 2

Avison YoungPrivate▲ Positive
Demandrelevance

Avison Young served as real estate advisor, gaining a client engagement.

DivcoWestPrivate▲ Positive
Demandrelevance

DivcoWest will have Collegium as a tenant at One Lincoln.

© 2026 MarketIVNews